This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Creatine and creatine phosphate are essential for intracellular storage and utilization of phosphate-bound energy. Aside from dietary sources, creatine is chiefly synthesized in liver in a 2-step enzymatic process (arginine:glycine amidinotransferase [AGAT] and guanidinoacetate methyltransferase), is carried via blood to target organs, and then transported using creatine transporter–1 into the tissues. Creatine deficiency syndromes related to each of the 2 enzymatic steps and creatine transporter–1 have been recently reported in patients with developmental delay and mental retardation.1 We report adult cases of myopathy in AGAT deficiency.
Case reports.
Case IV-30.
A 26-year-old Jordanian woman was born full-term to first-cousin parents (figure). She had moderate developmental delay in childhood; she began walking at age 20 months and speaking in monosyllables at age 6 years. At adolescence, she had impaired fine motor skills and speech difficulty but was independent in activities of daily living.
Figure Brain creatine levels in arginine:glycine amidinotransferase (AGAT) deficiency
(A) Pedigree chart showing consanguinity. (B, C) 1H magnetic resonance spectroscopy in IV-30 showing low creatine peaks (arrows) and …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen